Overview:  BigQuery demand is rising in 2026 as more companies rely on cloud data platforms for decision-making.The right BigQuery certification can improv ...

Immunotherapy plus radiation might provide a chemotherapy-free option for patients with locally advanced, mismatch repair-deficient (MMR-D) and microsatellite instability-high (MSI-H) endometrial ...

As part of the partnership, some of the specific courses include comprehensive training in Data Analytics (covering SQL, ...

EMS SQL Manager is a high-performance database management and administration tool designed for database professionals, developers, and IT teams. It delivers a comprehensive graphical interface for ...

Bireociclib plus fulvestrant nearly doubled progression-free survival compared with fulvestrant alone in HR-positive, HER2-negative advanced breast cancer. Benefits were consistent across high-risk ...

Free Gemini users can now generate images with real-time information, legible text, and more. Free Gemini users can now generate images with real-time information, legible text, and more. is a news ...

Video editing Mac users can efficiently produce professional-looking content on a MacBook Air thanks to iMovie's intuitive interface and the hardware acceleration of M-series chips. Beginners benefit ...

Versant, Comcast’s planned spin-off of select media brands and digital businesses, has signed a definitive agreement to acquire Free TV Networks (FTN), a provider of free over-the-air digital ...

Chinese AI startup DeepSeek has released two powerful new AI models that the company claims match or exceed the capabilities of OpenAI's GPT-5 and Google's Gemini-3.0-Pro — a development that could ...

Surveying the state of America’s artificial intelligence landscape earlier this year, Misha Laskin was concerned. Subscribe to read this story ad-free Get unlimited access to ad-free articles and ...

When graphic design platform-provider Canva bought the Affinity image-editing and publishing apps early last year, we had some major questions about how the companies’ priorities and products would ...

Ivonescimab plus chemotherapy improved PFS by 40% compared to Tevimbra in advanced squamous NSCLC, with a median PFS of 11.14 months versus 6.9 months. The study demonstrated consistent PFS benefits ...